Abstract
This study evaluated the safety and efficacy of the newly developed Revo-i (Meerecompany, Yongin, Republic of Korea) robotic surgical system during robot-assisted cholecystectomy. This prospective, phase I clinical study involved 15 patients with gallbladder-related disease. The primary outcome evaluated was the intraoperative safety of the Revo-i; the secondary outcomes measured were the 30-day postoperative complications and patient satisfaction with the Revo-i’s performance. Between August 17 and December 23, 2016, we performed 15 robot-assisted cholecystectomies. The operations were successfully completed, without any conversions to open or laparoscopic approaches. The mean patient age (53.07 years), mean operative time (115.3 ± 17.31 min [± standard deviation]), docking time (10.6 ± 3.16 min), console time (49.7 ± 15.41 min), actual dissection time (33.1 ± 10.53 min), and estimated blood loss (3.33 ± 6.17 mL) were determined. There were no intra- or postoperative complications, including gallbladder perforations. The mean hospital stay was 2.0 ± 1.00 days. Most patients reported satisfaction with the Revo-i’s performance. Performing robot-assisted cholecystectomies using the Revo-i is feasible and safe. This report describes the first clinical study of the Revo-i robotic surgical system in human patients.
| Original language | English |
|---|---|
| Journal | Updates in Surgery |
| DOIs | |
| Publication status | Accepted/In press - 2020 |
Bibliographical note
Funding Information:This work was supported by a National Research Foundation of Korea Grant, funded by the Korea Government (NRF-2015R1A2A2A04003460). The funding body did not have a role in the data collection, study design, or writing of the manuscript.
Funding Information:
This work was supported by a National Research Foundation of Korea grant funded by the Korea Government (NRF-2015R1A2A2A04003460). The funding agency had no role in the data collection, study design, or writing of the manuscript. Dr. W.J. Lee serves as a consultant for Meerecompany (Yongin, Republic of Korea). The other authors have no conflicts of interest or financial ties to disclose.
Funding Information:
This work was supported by a National Research Foundation of Korea Grant funded by the Korea Government (NRF-2015R1A2A2A04003460). The funding agency had no role in the data collection, study design, or writing of the manuscript. Dr. W. J. Lee serves as a consultant for Meerecompany (Yongin, Republic of Korea). He was not involved in the surgeries, data collection, or analyses. He provided advice about robotic systems and the setting up of a clinical trial. None of the other authors have conflicts of interest or financial ties to disclose.
All Science Journal Classification (ASJC) codes
- Surgery